Mercados españoles cerrados

Hologic, Inc. (HOLX)

NasdaqGS - NasdaqGS Precio en tiempo real. Divisa en USD
Añadir a la lista de favoritos
77,96+0,61 (+0,79%)
Al cierre: 04:00PM EDT
74,34 -3,62 (-4,64%)
Después del cierre: 05:46PM EDT

Hologic, Inc.

250 Campus Drive
Marlborough, MA 01752
United States
508 263 2900
https://www.hologic.com

Sector(es)Healthcare
SectorMedical Instruments & Supplies
Empleados a tiempo completo6990

Ejecutivos clave

NombreTítuloPagaEjecutadoAño de nacimiento
Mr. Stephen P. MacMillanChairman, CEO & President4,12M4,73M1964
Ms. Karleen M. ObertonChief Financial Officer1,6M490,44k1971
Mr. Essex D. MitchellChief Operating Officer925,29kN/A1980
Mr. John M. GriffinGeneral Counsel1,47M948,95k1961
Mr. Jan VerstrekenGroup President of International1,44MN/A1968
Mr. Paul MalenchiniChief Information OfficerN/AN/AN/A
Ryan M. SimonVice President of Investor RelationsN/AN/AN/A
Mr. Peter P. DunneSenior Vice President of Human ResourcesN/AN/A1956
Ms. Monica Aguirre BerthelotVP & Chief of StaffN/AN/AN/A
Mr. Erik S. AndersonDivision President of Breast & Skeletal Health SolutionsN/AN/A1982
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Gobierno corporativo

El ISS Governance QualityScore de Hologic, Inc., a día 1 de marzo de 2024, es 6. Las puntuaciones base son Auditoría: 6; Tablero: 6; Derechos de los accionistas: 7; Compensación: 4.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.